医学
临床试验
肿瘤科
内科学
不利影响
生物标志物
药物开发
药品
药理学
生物化学
化学
作者
Tim Schutte,Alaa Embaby,Neeltje Steeghs,Stevie van der Mierden,Willemien J. van Driel,Martin A. Rijlaarsdam,Alwin D. R. Huitema,Frans L. Opdam
标识
DOI:10.1016/j.ctrv.2023.102531
摘要
This report summarizes encouraging clinical development of WEE1i in gynecological cancers and considers its application in future studies. Biomarker-driven patient selection might be essential to increase the response rates.
科研通智能强力驱动
Strongly Powered by AbleSci AI